Conceptual Paper
Volume 10 Issue 8 - 2021
Diving into Cystic Fibrosis History: Major Milestones
Maria Moreno Ortega*, Macarena Queralt Garcı́a de Góngora and Isabel Delgado Pecellı́n
Paediatrician at the Children’s Hospital of the Virgen del Rocío University Hospital, Seville, Spain
*Corresponding Author: Maria Moreno Ortega, Paediatrician at the Children’s Hospital of the Virgen del Rocío University Hospital, Seville, Spain.
Received: June 17, 2021; Published: July 29, 2021

"Knowing the history of a disease indicates the way to reduce or eradicate it"

                                                                                                                              Marvin J Allison.

Cystic fibrosis (CF, OMIM # 219700, ICD-10 # E84) is a chronic, multisystemic disease, which classic clinical manifestations are respiratory infections, pancreatic insufficiency and increased sweat chloride concentration [1,2].

There are historical references related to these clinical manifestations for centuries before their description as a disease. As a first mention, the following 15th-century Irish saying would be 1 translated: “Woe to that child who, when kissed on the forehead, tastes salty. He is bewitched and will soon die” [1,3,4]. In 1606, Juan Alonso y de los Ruyzes de Fontecha, professor of Medicine at the University of Alcalá de Henares, wrote in their book "Ten privileges for pregnant women" [5]: "...he says he knows to bewitched people if when scratching their foreheads, you later once a salty taste on your fingers...”.


  1. Salcedo A., et al. “Tratado de Fibrosis Quística (2012): 551.
  2. Mall J. “Stuart MAE, editor. Cystic Fibrosis”. European Respiratory Society (2014): 332.
  3. Navarro S. “Recopilación histórica de la fibrosis quística”. Journal of Gastroenterology and Hepatology1 (2016): 36-42.
  4. Astudillo P. “Historia de la fibrosis quística (2020).
  5. Diez previlegios para mugeres preñadas. Con un diccionario medico - Juan-Alonso de Fontecha - Google Libros (2020).
  6. Busch R. “On the history of cystic fibrosis. Acta Universitatis Carolinae”. Medica 36 (1990): 13-15.
  7. Cheng TO. “Chopin’s Illness”. Chest2 (1998): 654.
  8. Wiy M., et al. “A Closer Look at Frederic Chopin’s Cause of Death”. American Journal of Medicine 131 (2018): 211-212.
  9. Majka L., et al. “Cystic fibrosis - A probable cause of Frédéric Chopin’s suffering and death”. Journal of Applied Genetics 44 (2003): 77-84.
  10. O’Shea JG. “Was Frédéric Chopin’s illness actually cystic fibrosis?” Medical Journal of Australia11-12 (2020): 586-589.
  11. Landsteiner K. “Darmverschluss durch eingeductes meconium pankreatitis”. Zentralblatt für allgemeine Pathologie 16 (1905): 903-907.
  12. Fanconi G., et al. “Das Coeliakie-syndrom bei angeborener zysKscher Pankreasfibromatose und Bronchiektasien”. Wiener Medizinische Wochenschrift (1936).
  13. DH A. “Cystic fibrosis of the pancreas and its relation to celiac disease: A clinical and pathologic study”. The American Journal of Diseases of Children (1938).
  14. Blackfan KD and May CD. “Inspissation of secretion, dilatation of the ducts and acini, atrophy and fibrosis of the pancreas in infants. A clinical note”. The Journal of Pediatrics (1938).
  15. Farber S., et al. “Pancreatic Enzyme Activity and the Celiac Syndrome”. Journal of Clinical Investigation6 (1943): 827-838.
  16. Andersen DH and Hodges RG. “Celiac syndrome; genetics of cystic fibrosis of the pancreas, with a consideration of etiology”. The American Journal of Diseases of Children (1946).
  17. Di Sant’agnese PEA and Andersen DH. “Celiac syndrome; chemotherapy in infections of the respiratory tract associated with cystic fibrosis of the pancreas; observations with penicillin and drugs of the sulfonamide group, with special reference to penicillin aerosol”. The American Journal of Diseases of Children (1946).
  18. DI Sant’agnese PA., et al. “Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease”. Pediatrics (1953).
  19. Gibson LE and Cooke RE. “A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis”. Pediatrics (1959).
  20. Mayhews LRW., et al. “A therapeutic regimen for patients with cystic fibrosis”. The Journal of Pediatrics (1964).
  21. Doyle B. “Physical therapy in the treatment of cystic fibrosis. - PubMed – NCBI”. Physical Therapy Reviews 1 (1959): 24-27.
  22. Crozier DN. “Cystic fibrosis. A not so fatal disease”. Pediatric Clinics of North America (1974).
  23. Knowles M., et al. “Increased Bioelectric Potential Difference across Respiratory Epithelia in Cystic Fibrosis”. The New England Journal of Medicine 25 (1981): 1489-1495.
  24. Quinton PM. “Chloride impermeability in cystic fibrosis”. Nature (1983).
  25. Tsui LC., et al. “Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker”. Science 80 (1985).
  26. Wainwright BJ., et al. “Localization of cystic fibrosis locus to human chromosome 7cen-q22”. Nature 6044 (1985): 384-385.
  27. Rommens JM., et al. “Identification of the cystic fibrosis gene: Chromosome walking and jumping”. Science 80 (1989).
  28. Crossle JR., et al. “Dried-Blood Spot Screening For Cystic Fibrosis In The Newborn”. Lancet 8114 (1979): 472-474.
  29. Wilcken B., et al. “Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infants”. The Journal of Pediatrics 3 (1983): 383-387.
  30. Gilbert J., et al. “Home intravenous antibiotic treatment in cystic fibrosis”. Archives of Disease in Childhood (1988).
  31. Hodson ME., et al. “Aerosol Carbenicillin And Gentamicin Treatment Of Pseudomonas Aeruginosa Infection In Patients With Cystic Fibrosis”. Lancet (1981).
  32. Yacoub MH., et al. “Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation”. The Journal of Heart and Lung Transplantation (1990).
  33. Mieles LA., et al. “Liver transplantation in cystic fibrosis”. Lancet8646 (1989): 1073.
  34. Hyde SC., et al. “Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy”. Nature (1993).
  35. Zabner J., et al. “Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis”. Cell (1993).
  36. Fuchs HJ., et al. “Effect of aerosolized recombinant human dnase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis”. The New England Journal of Medicine (1994).
  37. Ramsey BW., et al. “Intermiyent administration of inhaled tobramycin in patients with cystic fibrosis”. The New England Journal of Medicine (1999).
  38. Taylor CJ and Dodge JA. “High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis”. Lancet (1994).
  39. Saiman L., et al. “Azithromycin in Patients with Cystic Fibrosis Chronically Infected with Pseudomonas aeruginosa: A Randomized Controlled Trial”. The Journal of the American Medical Association (2003).
  40. Rogers CS., et al. “Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs”. Science (2008).
  41. Sun X., et al. “Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis”. Journal of Clinical Investigation (2010).
  42. Derichs N. “Targeting a genetic defect: Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis”. European Respiratory Review (2013).
  43. Boyle MP and De Boeck K. “A new era in the treatment of cystic fibrosis: Correction of the underlying CFTR defect”. The Lancet Respiratory Medicine (2013).
  44. Castellani C., et al. “Benchmarks for Cystic Fibrosis carrier screening: A European consensus document”. Journal of Cystic Fibrosis 9 (2010): 165-178.
  45. Flume PA., et al. “Ivacahor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation”. Chest (2012).
  46. Chaudary N. “Triplet CFTR modulators: Future prospects for treatment of cystic fibrosis”. Therapeutics and Clinical Risk Management (2018).
Citation: Maria Moreno Ortega., et al. “Diving into Cystic Fibrosis History: Major Milestones”. EC Pulmonology and Respiratory Medicine 10.8 (2021): 55-60.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before September 28, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to